Alternating Hemiplegia of Childhood Clinical Trial
Official title:
Role of Alternating Hemiplegia of Childhood Genotype in Cardiac Repolarization. HEART: HEmiplegia Arrhythmia Retrospective Trial
Alternating Hemiplegia of Childhood (AHC) is a rare and severe disease that is in need of effective, and hopefully even curative, therapies. Afflicted patients suffer from severe paralyzing crises, often excruciatingly painful muscle spasms, severe often life threatening epileptic seizures, frequently severe developmental and psychiatric/psychological disabilities and other comorbidities, such as cardiac disturbances. Recent data indicate that AHC genotype is in relation to cardiac repolarization troubles and to cardiac arrhythmias. The primary hypothesis to explore is that there is an association between genotype and cardiac phenotype in AHC.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03857607 -
Natural History Study of ATP1A3-related Disease
|
||
| Completed |
NCT00931164 -
Sodium Oxybate in Patients With Alternating Hemiplegia of Childhood (AHC-SO)
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT06248645 -
Oxygen as an Acute Treatment in Alternating Hemiplegia of Childhood
|
Phase 2 | |
| Completed |
NCT02408354 -
Pilot Study, Comparative, Single-center, Randomized, Crossover, Double-blind, Against Placebo, Testing the Effectiveness of Triheptanoin Oil in Alternating Hemiplegia of Childhood
|
Phase 2 |